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Abstract
Purpose: Simultaneous positron emission tomography–magnetic resonance imaging (PET-MRI) is an emerging technology
providing both anatomical and functional images without increasing the scan time. Compared to the traditional PET/computed
tomography imaging, it also exposes the patient to significantly less radiation and provides better anatomical images as MRI
provides superior soft tissue characterization. Using PET-MRI, we aim to study interactions between cartilage composition and
bone function simultaneously, in knee osteoarthritis (OA).
Procedures: In this article, bone turnover and remodeling was studied using [18F]-sodium fluoride (NaF) PET data. Quantitative
MR-derived T1r relaxation times characterized the biochemical cartilage degeneration. Sixteen participants with early signs of OA
of the knee received intravenous injections of [18F]-NaF at the onset of PET-MR image acquisition. Regions of interest were
identified, and kinetic analysis of dynamic PET data provided the rate of uptake (Ki) and the normalized uptake (standardized
uptake value) of [18F]-NaF in the bone. Morphological MR images and quantitative voxel-based T1r maps of cartilage were
obtained using an atlas-based registration technique to segment cartilage automatically. Voxel-by-voxel statistical parameter
mapping was used to investigate the relationship between bone and cartilage.
Results: Increases in cartilage T1r, indicating degenerative changes, were associated with increased turnover in the adjoining
bone but reduced turnover in the nonadjoining compartments. Associations between pain and increased bone uptake were seen
in the absence of morphological lesions in cartilage, but the relationship was reversed in the presence of incident cartilage lesions.
Conclusion: This study shows significant cartilage and bone interactions in OA of the knee joint using simultaneous [18F]-NaF
PET-MR, the first in human study. These observations highlight the complex biomechanical and biochemical interactions in the
whole knee joint in OA, which potentially could help assess therapeutic targets in treating OA.
Keywords
PET-MRI, multimodality imaging, knee osteoarthritis, sodium fluoride imaging, bone–cartilage interactions, T1r relaxation times,
voxel-by-voxel statistical parameter mapping, bone remodeling, cartilage degeneration
Introduction
Osteoarthritis (OA) is a degenerative joint disease and a lead-
ing cause of chronic disability in the United States. The initial
signs of OA include cartilage degeneration manifested as mole-
cular and biochemical changes within the extracellular matrix.
Changes in joint kinematics and biomechanical load distribu-
tion have been implicated in the initiation of OA. A conserva-
tive overall estimate of OA prevalence in the United States was
estimated to be 26.9 million US adults in 2005.1 The incidence
of OA is expected to increase to 59 million by the year 2020.2
The World Health Organization estimates OA to be the leading
cause of chronic disability in 10% of the population older than
60 years,3 and knee OA is associated with chronic disability as
often as heart and lung disease.4
1 Department of Radiology and Biomedical Imaging, University of California,
San Francisco, San Francisco, CA, USA
2 Department of Physiology, Anatomy and Genetics, University of Oxford,
Oxford, United Kingdom
Submitted: 13/06/2016. Revised: 05/10/2016. Accepted: 14/11/2016.
Corresponding Author:
Dragana Savic, Department of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, CA 94143, USA.
Email: dragana.savic@dpag.ox.ac.uk
Molecular Imaging
Volume 15: 1-12
ª The Author(s) 2016
Reprints and permission:
sagepub.com/journalsPermissions.nav
DOI: 10.1177/1536012116683597
journals.sagepub.com/home/mix
Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License
(http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further
permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Joint space narrowing (JSN), as measured by radiographs, is
the current gold standard and the criterion for OA progression
in clinical trials as accepted by the Food and Drug Adminis-
tration. Radiograph-based Kellgren-Lawrence (KL)5 scores are
used to categorize participants based on the severity of OA.
Long before changes in joint space can be detected, and mor-
phological changes in cartilage occur, a depletion of proteogly-
can and an increase in water content and disruption of the
collagen network occurs. The symptoms include stiffness, lim-
ited joint function, and pain, which lead to a decrease in quality
of life. Pain is one of the most important outcome measures in
OA and is measured using questionnaires and patient-reported
outcomes, such as the Knee Osteoarthritis Outcome Score
(KOOS). The early biochemical changes in cartilage are not
reflected in the KL grade or JSN from radiographs, but the
KOOSs or pain is a measure of symptomatic OA.
Magnetic resonance imaging (MRI), with its superior soft
tissue contrast, image resolution, and 3-dimensional (3D) ima-
ging capabilities, has been widely studied in an effort to
develop quantitative biomarkers for OA and fill the void that
exists for diagnosis, monitoring, and assessment of soft tissue
characterization and whole-joint degeneration in OA. Scoring
systems such as the Whole-Organ Magnetic Resonance Ima-
ging Score (WORMS)6 grade cartilage lesions and correlate
lesion severity with other findings such as meniscal defects,
the presence of bone marrow lesions, as well as radiographic
and clinical scores.7-9 Magnetic resonance-derived T1r and T2
assess the structural and biochemical properties of cartilage
such as changes in collagen (T2)
10 and proteoglycan
(T1r),
11,12 which are both increased in patients with OA com-
pared to control groups.13,14 In addition to differences in mean
and compartmental averages of T1r and T2, studies have
demonstrated differences in the spatial heterogeneity of these
measures between normal controls and patients with OA.15-17
Early changes inOAare also seen in the adjoining subchondral
and trabecular bone. Articular cartilage and subchondral bone act
in concert during mechanical loading of the joint. The subchon-
dralmineralizedzoneplays an important role in reducing the axial
impact forces, typically encountered during dynamic joint load-
ing18 and adapts to the mechanical demands during normal and
abnormal joint loading.19-21 A hypothetical model for OA patho-
genesis has been proposed by Burr and Gallant,22 whereby repe-
titive joint loading causes an initial increase in bone remodeling
that is associated with increased vascular invasion of the deep
layers of cartilage,which allowsunopposed access to the cartilage
by chondrolytic enzymes. These enzymes cause a breakdown of
the extracellular matrix, loss of proteoglycan and collagen, and
thus a loss of cartilage compressive stiffness, and an overload of
the joint. Some of these bone remodeling changes are visible on
positron emission tomography (PET) imaging. Paradoxically
both early-stage increased remodeling and bone loss and the
late-stage slow remodeling and subchondral densification are
important components of the pathogenic process that leads toOA.
Using MRI for quantifying trabecular architecture, investiga-
tors have found a relationship between bone structure and articu-
lar cartilage morphology in patients with OA, especially the loss
of trabecular bone in regions not adjoining the regions of cartilage
loss.23,24 Subchondral bone changes are present prior and during
the development of OA and increased bone blood flow and bone
remodeling, as demonstrated by [18F]-sodium fluoride (NaF)
PET,25may be associatedwith patellofemoral pain and later stage
morphological changes in cartilage. Draper et al25 showed that
pain is correlated to mean normalized standardized uptake value
(SUV) measures obtained from PET imaging; so detecting early
changes in bone remodeling could help in understanding the dis-
ease, relate it to changes in cartilage andwhole-joint degeneration
and possibly prevent the progression of OA, and provide strate-
gies for reducing symptomatic OA in the future. As the authors25
describe that even though most edema and cartilage lesions are
present, bone metabolic abnormalities are seen where no lesions
or structural changes are present on MR images.
The primary goal of this first-in-human study was to demon-
strate bone–cartilage interactions in the whole knee joint in
patients with OA using simultaneous PET-MRI to understand
the pathophysiology of the disease. Positron emission tomogra-
phy and MR provide different information about the OA in a
patient and by combining these two modalities, we can obtain
better and more accurate information about the pathophysiol-
ogy of the disease and its progression.
The interaction between the bone and the cartilage is espe-
cially critical in early onset of the disease not only to determine
the disease profile but also be able to detect early changes that
most likely will show in the bone and therefore will be visible
on PET imaging prior to the MRI of the disease.
With simultaneous detection of early cartilage biochemical
degeneration using quantitative MR and bone remodeling in
adjoining and nonadjoining regions, we can elucidate the nat-
ural history of the disease and assess therapeutic targets in the
treatment of OA in the future.26,27
Materials and Methods
Patient Population
Sixteen patients with knee OA (radiographic or symptomatic)
were recruited compliant with the regulations of the Committee
of Human Research (CHR), the institutional review board (IRB)
at the University of California, San Francisco. Prior to the start of
the study, all patients signed a written consent form approved by
the CHR. The inclusion criteria were age >35 years, knee pain,
aching, or stiffness on most days per month during the past year,
or use of medication for knee pain on most days per month
during the past year. The exclusion were (1) concurrent use of
an investigational drug, (2) history of fracture or surgical inter-
vention in the study knee, and (3) contraindications to MR.
Radiographs were obtained from all patients to determine the
KL score as a metric of prevalence and severity of radiographic
OA. The score ranged from 0 to 4, where 0 showed no features of
OA on the radiographs and 4 showed large osteophytes, JSN,
severe sclerosis, and definite bony deformity.5
All patients filled the validated patient-reported outcomes
questionnaire (KOOS)28 that provided a metric of pain,
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stiffness, and scores ranged from 0 to 100, where lower scores
represented higher pain and symptomatic OA.
Positron Emission Tomography-Magnetic Resonance
Imaging Examination Protocol
An intravenous catheterwasplaced, and thepatientwaspositioned
feet-first in a 3-T PET-MR scanner (GE Healthcare, Milwaukee,
Wisconsin). An external medium-sized RF flex coil (GE Health-
care) was used due to the significantly lower attenuation effect on
the PET signal (ie, low rate of stopping, 511 keV photons) com-
pared to the conventional knee coil. The patients were injected
with an average of 340.4 MBq of [18F]-NaF at the onset of the
PET-MRscan.AdynamicPETscanwas acquired fromthe timeof
injection for 60minuteswithMRsequences running concurrently.
TheMRI sequences acquired simultaneously with the PET acqui-
sitionwere (1) high-resolution3D fast spin echo (FSE,CUBE)and
(2) quantitative sagittal 3D combined T1r/T2 (Table 1).
29 All PET
reconstructionswere performed using 3DOrdered Subsets Expec-
tation Maximization algorithm with time-of-flight temporal reso-
lution of approximately 400 ps. Magnetic resonance acquisition
parameters and PET acquisition parameters are shown in Tables 1
and 2, respectively.
Magnetic Resonance Grading for Assessing Cartilage
Lesions and OA Status
A board-certified radiologist (M.B.) graded the morphological
MR images (CUBE, Table 1) using WORMS grading.6
Cartilage lesions were graded as WORMS ¼ 0 (normal thick-
ness), WORMS ¼ 1 (normal thickness, but increased signal
intensity), WORMS¼ 2 (partial thickness focal lesion less than
1 cm at greatest width), WORMS ¼ 2.5 (full thickness focal
lesion less than 1 cm at greatest width), WORMS¼ 3 (multiple
areas of partial lesions less than 1 cm at greatest width, or a
grade 2 lesion wider than 1 cm, but less than 75% of the
region), WORMS ¼ 4 (diffuse partial thickness loss greater
than 75% of the region), WORMS ¼ 5 (multiple areas of full
thickness lesion greater than 1 cm but less than 75% of the
region), and WORMS ¼ 6 (diffuse full thickness loss greater
than 75% of the region). The summary of patient characteristics
is shown in Table 3.
Positron Emission Tomography Image Analysis
Physiologically, after intravenous injection of the radiophar-
maceutical, [18F] ions are extracted from plasma in proportion
to bone perfusion and quantitative studies of uptake are possi-
ble using dynamic PET.30 The uptake of the fluoride ion in
bone is rapid and the initial uptake is a function of bone blood
flow; after residing in the perivascular fluid, an exchange of the
fluoride ion with hydroxyl groups in the hydroxyapatite occurs
and this is proportional to the surface area of the bone available,
which is typically higher in immature bone, with high osteo-
blastic activity and remodeling.31,32 The rate constants for
these physiological processes calculated by the Patlak analysis
method using dynamic multiframe data of PET in a region of
interest (ROI) involves linear regression of curve fitting. Haw-
kins et al showed that a multicompartment nonlinear model
including both bound and unbound fluoride ions were in good
agreement with Patlak analysis as used in this study.33 The
Patlak graphical analysis method provided the influx rate con-
stant Ki from the slope of the linear portion of the plot, reflect-
ing bone remodeling. Both kinetic and simplified models have
been shown to accurately quantify bone turnover using
[18F]-NaF PET.34 The most widely used parameters for semi-
quantification of PET measures, which do not require dynamic
acquisitions, are the standardized uptake values (SUVavg and
Table 1. Magnetic Resonance Imaging Acquisition Parameters.a
MR Imaging
Sequence Acquisition Parameters Measurements
3 plane
gradient
echo
Localizer – For
Choosing
Coverage
High
resolution
3D FSE
(Cube)
TR/TE ¼ 1500/26.69 ms,
FOV ¼ 16 cm,
Matrix size ¼ 384 x 384,
Echo train ¼ 32,
Slice thickness ¼ 0.5
Semi-quantitative
scores WORMS
Quantitative
combined
T1r /T2
mapping
using
MAPSSb
TE ¼ 0/12.87/25.69/51.39 ms,
TSL ¼ 0/10/40/80 ms,
Locking Frequency ¼ 500 Hz,
FOV ¼ 14 cm,
Matrix size ¼ 256 x 128,
Slice thickness ¼ 4.0 mm
Cartilage/Meniscus
T1r and T2 mean,
laminar
Abbreviations: 3D, three-dimensional; FSE, fast spin echo; MRI, magnetic reso-
nance imaging; TE, echo time; TR, repetition time; WORMS, Whole-Organ
Magnetic Resonance Imaging Score; TSL, Spin-Lock Time; FOV, Field of View.
aThe table lists the MR acquisition parameters for the 3 MR sequences used:
(1) localizer, (2) high-resolution 3D FSE CUBE, and (3) quantitative combined
T1r/T2.
bXiaojan LI, Magn Reson Med. In vivo T(1rho) mapping in cartilage using 3D
magnetization-prepared angle-modulated partitioned k-space spoiled gradient
echo snapshots (3D MAPSS).Magn Reson Med. 2008 Feb; 59(2):298-307.
Table 2. Positron Emission Tomography Acquisition Parameters.a
Dynamic PET acquisition parameters
Acquisition time 60 min
Onset after injection 0 min
Number of Phases 3
Number of Frames/Phase 12 frames of 10 s 4 frames of 30 s
14 frames of 4min
Transverse Filter Cutoff 3 mm
Subset 28
Iterations/Axil Filter 4/Standard
Measures SUVmax, SUVavg, Slope Ki
Abbreviations: avg, average; PET, positron emission tomography; max, maxi-
mum; SUV, standardized uptake value.
aThe table lists the PET acquisition parameters for the dynamic PET
acquisition.
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SUVmax) that are a measure of uptake and bone remodeling in
case of [18F]-NaF, within a ROI decay corrected and normal-
ized for the injected activity and for patient weight or lean
body mass.
All bone ROIs were manually segmented as circular regions
of interest in PMOD (PMOD Technologies Ltd, Zurich, Swit-
zerland). All bone regions that were segmented were adjacent
to the respective cartilage regions (ROIs)—patella (P), trochlea
(TrF), medial femur (MF), medial tibia (MT), lateral femur
(LF), and lateral tibia (LT). The regions were the same size
across all patients and did not overlap with the cartilage. The
last 10 minutes of the 60-minute dynamic PET acquisition were
summed, and the data were analyzed with both maximum and
average SUVs (SUVmax and SUVavg). The entire 60-minute
PET acquisition was used to do kinetic analysis by using the
data from an ROI placed in the popliteal artery as the input
function. The input function was corrected for the partial vol-
ume effect by acquiring phantom data with different sized
cylinders, with known activity and correcting for the partial
volume. The 60-minute dynamic PET data were assessed using
a linear Patlak graphical analysis method; the slope from the
Patlak plot, Ki (ie, [
18F]-NaF influx rate contrast—an estimate
of uptake rate) in each bone compartment (adjacent to the
cartilage compartments) was computed. Average and maxi-
mum SUVs (SUVavg and SUVmax) and the Ki values can be
seen in Table 4.
Table 3. Patient Evaluation.a
Patient Age, Years BMI, kg/m2 NaF, MBq KL Grade KOOS Pain
WORMS
P TrF MF LF MT LT
1 52.00 26.31 329.3 3 100 2 3 3 0 3 1
2 53.00 29.13 340.4 1 100 0 0 0 0 0 0
3 60.00 19.37 340.4 1 83.33 2.5 0 0 0 0 1
4 74.00 26.95 366.3 1 100 3 0 0 0 0 0
5 38.00 24.66 362.6 0 97.22 0 0 0 0 0 0
6 47.00 19.14 284.9 0 44.44 0 0 0 0 0 0
7 57.00 27.02 240.5 1 100 2 2 0 0 0 0
8 64.00 25 358.9 0 91.67 1 0 0 0 0 0
9 54.00 21.12 355.2 3 91.67 3 2.5 0 0 0 0
10 60.00 27.29 340.4 2 61.11 2 0 0 0 0 0
11 40.00 24.33 362.6 0 50 0 0 0 0 0 0
12 59.00 29.41 299.7 0 30.56 0 3 0 0 0 0
13 59.00 18.72 370 0 50 3 0 0 0 0 0
14 66.00 21.42 340.4 0 94.44 0 2 0 0 0 0
15 61.00 31.62 351.5 2 100 4 0 2 2 0 2
16 59.00 28.17 358.9 0 50 2.5 3 0 6 0 6
Abbreviations: BMI, body mass index; KL, Kellgren-Lawrence; KOOS, Knee Osteoarthritis Outcome Score; LF, lateral femur; LT, lateral tibia; MF, medial femur;
MT, medial tibia; NaF, sodium fluoride; P, patella; TrF, trochlea; WORMS, Whole-Organ Magnetic Resonance Imaging Score.
aData are for all patients. Age, BMI, and [18F]-NaF injected (MBq) for each patient. KL grade based on radiographs are listed, as well as KOOS pain from the
questionnaires and WORMS grades in each cartilage region.
Table 4. Summary of Patient Data.a
P TrF MF LF MT LT
PET variables
Slope Ki avg 0.0048 0.0021 0.0026 0.0026 0.0025 0.0025
Slope Ki std 0.0039 0.0014 0.0015 0.0014 0.0010 0.0012
SUVavg avg 1.4 0.7 0.8 0.8 0.8 0.8
SUVavg std 1.1 0.3 0.4 0.5 0.4 0.3
SUVmax avg 3.6 1.5 1.7 1.7 1.7 1.6
SUVmax std 2.9 0.8 0.8 0.9 0.7 0.8
Quantitative MR variables
T1r avg 42.6 44.4 41.6 41.2 36.9 34.9
T1r std 4.5 4.7 3.6 5.1 4.8 5.8
Abbreviations: avg, average; KL, Kellgren-Lawrence; KOOS, Knee Osteoarthritis Outcome Score; LF, lateral femur; LT, lateral tibia; max, maximum; MF, medial
femur; MR, magnetic resonance; MT, medial tibia; P, patella; PET, positron emission tomography; std, standard; TrF, trochlea.
aPositron emission tomography and MR variables as well as radiographic scorings (KL) of the patient. The KOOS pain scores grouped from 0 (high pain) to 100 (no
pain) and the number of patients (n). Average and standard deviation values are presented for PET and MR variables in all compartments (P, TrF, MF, LF, MT, and
LT).
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Quantitative MR Image Analysis
All cartilage regions were automatically segmented as
described by Pedoia et al.35 One patient with average weight
and body mass index (BMI) was selected as the reference. Six
ROIs were semiautomatically segmented on the reference
image—P, TrF, MF, LF, MT, and LT. The 3D FSE CUBE
previously rigidly registered on the first Spin-Lock Time (TSL)
image of T1r sequence was used for the semiautomatic seg-
mentation of the reference. Piecewise rigid registration was
applied along the echoes to take into account nonrigid move-
ment of the articulation during the scan. Cartilage ROIs were
used to define the borders of the 3 masks that only included the
femur, tibia, and P bones. Those masks were then used to
constrain the piecewise registration. Each registration was initi-
alized by the results of the one obtained on the previous echo;
this approach allowed for good registration performances even
in the later echoes characterized by poor SNR.
Nonrigid registration of all images on the reference space
was performed. T1r maps were obtained by fitting the trans-
formed T1r-weighted images using a Levenberg-Marquardt
monoexponential, (SðTSLÞ / eTSL= T 1r), applied on each
voxel. After the registration, the reference’s ROIs were over-
laid on all maps in the data set allowing for a fully automatic
atlas-based segmentation and voxel-based analysis of compara-
tive regions between patients. This allowed for analyzing data-
driven subcompartments and layers based in the relaxation
parameters pattern instead of defining a priori subdivision.
Pearson partial correlation was used to assess association
between bone remodeling and cartilage biochemistry measures
at the voxel-level adjusting for age, gender, BMI, and KOOS
pain. An R value volumetric statistical parametric maps
(SPMs) for each measure was obtained in the overall segmen-
ted cartilage. Clusters of significant voxels were defined with
the same R sign and P < .05. Significance could be viewed at the
level of the individual voxels; however, to avoid by chance
correlations, a size threshold was set such that a cluster of adja-
cent neighboring pixels was considered for further analysis, if
the size of the cluster (number of voxels in the cluster) relative to
the total number of voxels in the compartment was greater than
or equal to 8% of the size of the entire compartment. This thresh-
old was selected empirically and kept constant.
Three-dimensional representations of the SPM were gener-
ated using a technique based on Laplace equation, previously
used to generate cartilage thickness maps.36 The technique
yields a one-to-one matching between points in the bone–
cartilage interface and points in the articular surface with no
crossings. Laplace equation was numerically solved in 3
dimensions with Dirichlet boundary conditions obtaining a
potential map. A vector field was generated to lead each point
in the bone–cartilage interface to a point in the articular surface.
Average R values along this trajectory are computed and pro-
jected on the triangulated mash obtained from 3D bone segmen-
tation of the reference knee. A visual inspection of the SPMswas
then conducted to identify global pattern of association between
bone remodeling and cartilage relaxation times.
Results
Study Population
Sixteen patients with varying degrees of knee OA were studied
using an integrated PET-MR system (GE Healthcare, Wauke-
sha, Wisconsin). Table 3 lists the patient demographics, isotope
dose, the OA status, and pain. The average age of the patients
was 57 years and average BMI was 25.3 kg/m2. The average
[18F]-NaF dose injected was 340.4 MBq in 11 males and
5 females. Twelve of the patients had minimal or no sign of
radiographic OA (KL grade 0 and 1); however, they did have
some pain based on the KOOS questionnaires. Four of the
patients had either KL grade 2 (definite osteophytes—possible
JSN) or KL grade 3 (multiple osteophytes—definite JSN—
possible bony deformity). The patients had varying degrees
of pain assessed using the patient-reported questionnaire—
KOOS (average KOOS ¼ 78; range, 30.6-100). Magnetic
resonance-derived WORMSs showed the highest lesion load
in the patellar cartilage (Table 3). Quantitative MR images
provided T1r in each of the above cartilage compartments
(Table 4). Figure 1 shows an example of the T1r map of a
patient with KL grade 2 and WORMS grade 2 in the TrF. In
this example, the high spatial heterogeneity of the cartilage com-
position is notable; clusters of higher T1r in the articular layer of
the P and the TrF as well as in the MT are demonstrated.
Quantitative and Semiquantitative PET
The average and maximum [18F]-NaF uptake values as SUVavg
and SUVmax in all bone compartments (Figure 2A) were
plotted against [18F]-NaF uptake rate (slope Ki), which is
obtained from kinetic modeling with a linear Patlak method.
Slope Ki correlate with the semiquantitative SUVavg and
SUVmax (R
2 ¼ .7) in all bone compartments (Figure 2B and C).
Figure 1. Voxel-based T1r maps. An atlas-based voxel-by-voxel T1r
map that shows regions in the medial tibia (MT), the medial femur
(MF), patella (P), and in the trochlea (TrF). The T1r color maps are
overlaid on a gray scale magnetic resonance (MR) image and the color
bar represents relaxation times from 0 ms (blue) to 70 ms (red).
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The uptake rate defined by slope Ki obtained from the Patlak
method in all compartments is presented as (average + stan-
dard deviation)—P: 0.005 + 0.0039, TrF: 0.0023 + 0.0017,
MF: 0.0028+ 0.0017, MT: 0.0028+ 0.0014, LF: 0.0028+
0.0015, and LT: 0.0027+ 0.0013 (Table 5).
A significant difference (paired t test, P < .05) was found in
the P compartment compared to all other bone compartments
and between the TrF and the LF as well as between the TrF and
the MF bone. Ten (63%) patients had the fastest uptake rate in
the P (slope Ki). In 25% of the patients, the highest uptake rate
was in the lateral and MT resulting in the tibia being the com-
partment with the second fastest average uptake rate. However,
the average slope Ki in the tibia was only significantly different
from P (Table 5). The same trends are seen for SUVmax, where
63% of the patients have the highest uptake in the P (SUVmax)
and the second highest [18F]-NaF uptake is found in the femur.
The average standardized uptake values (SUVavg) showed a
dependence on the presence of lesions in the P but also on the
patient’s pain (Table 5). In patients with WORMS of 0 and 1
indicating no lesions, or mild OA, the patients with pain had
higher SUVavg values (SUVavg ¼ 2.0) compared to those with-
out pain (SUVavg ¼ 0.9), showing significant trends, P < .1.
However, in the presence of morphological lesions in cartilage,
WORMS >1, those without pain (SUVavg ¼ 1.9) had higher
SUVavg values compared to those with pain (SUVavg ¼ 0.8),
also approaching significance, P < .1.
Knee Bone–Cartilage Interactions
Correlations between the remodeling in the bone and degenera-
tion in the cartilage were observed across several bone and
cartilage compartments, and interactions were seen in adjacent
regions but also in compartments, which were not adjoining.
The highest correlations between the PET values from the bone
and the T1r values from the cartilage were seen with Ki in the
MT (Figure 3), and with the SUVmax in the P (Figure 4) and in
the LT (Figure 5). The color bar ranges from strong negative
correlations (light blue, purple, and blue) to strong positive
correlations (red, green, and yellow) denoted with a correlation
coefficient, R (range: 1.0 to 1.0, where the P value ¼ 0.0001
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Figure 2. Correlations between quantitative and semiquantitative positron emission tomography (PET) measures. A, PET-magnetic resonance
(MR) fused image in the lateral and medial side of the knee. Bone compartments are showed as regions of interest (ROIs) in the lateral and
medial side of the knee in compartments—patella (P), trochlea (TrF), lateral femur (LF), lateral tibia (LT), medial femur (MF), medial tibia (MT).
B and C, Correlations between NaF uptake at 60 minutes (standardized uptake value [SUV]) in all bone compartments plotted with the uptake
rate (Ki) in the same compartments. SUVavg and SUVmax have high correlations with slope Ki (R
2 ¼ .71 and 0.69).
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for R¼+.8). A scatterplot for the average values for all patients
are depicted in the white box selected regions (Figures 3–5),
where there are large clusters of voxels with moderate to strong
correlations. The ellipse represents 95% confidence interval.
The slope Ki obtained from the MT bone was correlated with
the T1r relaxation times in the cartilage of the MT, the posterior
MT, P, and TrF (Figure 3).
A strong positive correlation was observed between T1r
relaxation times in the cartilage of the MT with the MT slope
Ki (R ¼ .68, P ¼ .0014), and similarly in the P (R ¼ .75,
P ¼ .0045), whereas a moderate negative correlation was
observed in the TrF with the MT slope Ki (R ¼ .48, P ¼ .066;
Figure 3).
The SUVmax in the P bone was correlated with the T1r in the
bone layer of the cartilage (R ¼ .42, P ¼ .10), and the articular
layer (R ¼ .50, P ¼ .048) of the P cartilage, and the SUVmax in
the P bone was strongly negatively correlated with T1r from the
TrF cartilage (R ¼ .72, P ¼ .002; Figure 4).
The SUVmax in the LT bone was correlated with T1r in the
LT cartilage (R ¼ .74, P ¼ .0042), LF cartilage (R ¼ .71,
P ¼ .0062), and MF cartilage (R ¼ .61, P ¼ .012; Figure 5).
Discussion
Kinetic [18F]-NaF/T1r PET-MR studies were performed in
patients with different degrees of knee OA at the University
of California, San Francisco, to investigate the interaction of
the cartilage with the bone. A direct correlation was identified
between the cartilage biochemistry, quantitative MR bio-
metrics, and PET evidence of bone remodeling in patients with
knee OA. This demonstration of bone–cartilage interactions in
patients with knee OA in adjoining and nonadjoining regions
leads us to speculate about the concept of the Bone–Cartilage
Connectome. Our results support the complex interplay
between biomechanics and joint loading as well as biochemis-
try and tissue degeneration as a composite in OA, a disease
affecting the whole joint, showing even trends with pain. Both
imaging modalities are critical to obtain a comprehensive over-
view of the disease to get to the core of the pathophysiology of
OA with the aim of treatment; however, larger longitudinal
studies are further needed.
Despite the relatively small sample size, the correlations
between [18F]-NaF uptake in the bone, morphological lesions
in MR, and pain scores approached statistical significance
(P < .1). Based on our results, we speculate that early OA is
initiated by increases in repetitive loading of the P, with sub-
sequent increases in bone remodeling and release of degrada-
tive proteinases, which depletes proteoglycan from the
extracellular cartilage matrix. On MRI, this manifests as
increases in T1r. Several knee nerve endings are close to the
patellar fat pad; we speculate that the degradative enzymes
irritate the nerve endings, giving rise to pain. Pain was present
in both knees with high and low metabolic activity, with dif-
ferent stages of OA suggesting that pain is complex and sub-
jective. It is likely that the threshold for feeling the pain is
dependent on the patient and on the length of the OA disease.
Studies showed that pain correlates with T2 relaxation times in
early OA and can therefore be a quantitatively measurable
biomarker for knee pain37,38; however, due to the small sample
size, this only approaches statistical significance in this study.
Given these findings, future studies will be able to study pain
more thoroughly using the PET-MRI technology and our
experimental setup as a basis.
A discrepancy between [18F]-NaF uptake and morphologi-
cal MR lesions in adjoining regions, along with increased
uptake in patients with pain was also seen by Draper et al,25
using PET/CT and MR that were done sequentially. Our study
confirmed the trend, however, our investigation of early
changes in cartilage biochemistry, the automatic atlas-based
segmentations35 and voxel-based T1r, and SPM further
revealed complex interactions. Subchondral bone is known to
be involved in OA development and subchondral sclerosis is
frequently seen in patients with OA, as is trabecular bone osteo-
penia. It remains unclear whether bone changes precede carti-
lage deterioration or are involved in the progression of the
disease.39 Interestingly, in this study, in the presence of mor-
phological lesions, lower remodeling was seen in patients with
pain. The MR morphological grading demonstrated multiple
areas of partial cartilage loss/defect in the TrF but no lesions
in the P. Patella showed both the highest and fastest remodeling
(Table 5), indicating that loading affects different knee com-
partments differently, perhaps due to biomechanical loading
and perhaps consistent with the findings of Hunter et al who
found that knee pain was highly associated to degeneration in
the cartilage of the P.38
Increased rate of bone turnover using both kinetic and SUV
data was seen in several compartments, where uptake of
Table 5. Sodium Fluoride Uptake Associated With Pain.a
Kinetic uptake rate of NaF; slope Ki (mean + SD)
P 0.005+ 0.0040
TrF 0.002+ 0.0017b
LT 0.003+ 0.0014b
MT 0.003+ 0.0015b
LF 0.003+ 0.0016b,c
MF 0.003+ 0.0017b,c
NaF uptake in the P; SUVavg (mean + SD)
No pain, no lesions (WORMS ¼ 0,1) 0.88+ 0.66d
Pain, no lesions (WORMS ¼ 0, 1) 2.03+ 1.23d
No pain, lesions (WORMS > 1) 1.96+1.38d
Pain, lesions (WORMS > 1) 0.84+0.81d
Abbreviations: KOOS, Knee Osteoarthritis Outcome Score; LF, lateral femur;
LT, lateral tibia; MF, medial femur; MT, medial tibia; NaF, sodium fluoride; P,
patella; SD, standard deviation; SUV, standardized uptake value; TrF, trochlea;
WORMS, Whole-Organ Magnetic Resonance Imaging Score.
a[18F]-NaF uptake rate (slope Ki) in the bone compartments (mean + SD),
comparison between compartmental uptake rate found with paired t test
(P < .05). [18F]-NaF uptake (SUVavg) in the bone of the P is divided into those
with lesion based on WORMS, and those without lesions, as well if they were
with pain (KOOS < 90) or without pain (KOOS > 90), these groups (NaF
uptake in the P; SUVavg) were approaching significance with an unpaired t test
with P < .1.
bSignificance <.05 compared to P.
cSignificance <.05 compared to TrF.
dApproaching significance P < .1.
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[18F]-NaF was seen simultaneously with early degenerative
changes in the cartilage. Increased bone turnover was also seen,
when there was mechanical overload, such as the contact areas,
which can also cause damage to the bone that leads to remodel-
ing, that does not necessary increase the bone density but could
cause bone turnover to increase.40 Burr and Schaffler suggested
that it was only the cartilage and the adjacent bone that was
significant for the disease progression of OA.39 However, in
this study, we found compelling evidence that it was not only
the adjacent regions that affect the health of the knee but also
bone remodeling at a greater distance to the cartilage regions
with increased stress as seen from T1r values from the
Figure 3. Voxel-based T1r maps from the cartilage correlated with slope Ki from the bone of the medial tibia (MT). The color map represents
the Pearson correlation R values representing positive and negative correlations. The right side shows the scatterplots of the average value of
the voxels in white dashed boxes from the magnetic resonance (MR) images. The ellipse illustrates the 95% confidence interval. (Top) Anterior
MT cartilage shows a strong positive correlation with the slope Ki from MT bone (R ¼ .68, P ¼ .0014). (Middle) The patella cartilage shows a
strong positive correlation with slope Ki from MT bone (R ¼ .75, P ¼ .0045). (Bottom) The trochlea (TrF) cartilage shows a moderate negative
correlation with slope Ki from MT bone (R ¼ .48, P ¼ .066).
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cartilage. In order to establish the relationship more con-
clusively, clearly, longitudinal data and larger sample sizes
are necessary.
As an example for the nonadjacent connection, the slope Ki
from the MT was positively correlated with the T1r in the
cartilage on the medial femoral-tibia side and on the P and was
Figure 4. Voxel-based T1rmaps from the cartilage correlated with standardized uptake value (SUVmax) in the bone of the patella (P). The color
map represents the Pearson correlation R values representing positive and negative correlations. The right side shows the scatterplots of the
average value of the voxels in white dashed boxes from the magnetic resonance (MR) images. The ellipse illustrates the 95% confidence interval.
(Top) The bone layer of the P cartilage shows a moderate positive correlation with SUVmax from the P bone (R ¼ .42, P ¼ .10). (Middle)
The articular layer of the P cartilage shows a moderate negative correlation with SUVmax from the P bone (R ¼ .50, P ¼ .048). (Bottom)
The trochlea (TrF) cartilage shows a strong negative correlation with SUVmax from the P bone (R ¼ 0.72, P ¼ .002).
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negatively correlated with T1r in the cartilage on the lateral
femoral-tibia side of the knee; this could relate to the loading
pattern of the knee, so that the loading shifts from the lateral
side of the knee to the medial. Vincent et al41 showed that once
OA has occurred, the mechanical and morphological
characteristics lead to further degeneration of the cartilage.
Using voxel-based relaxometry, we were able to distinguish
between different relationships between bone–cartilage associ-
ated with the different layers of the cartilage, this was seen in
several compartments, such as the TrF and the LT but
Figure 5. Voxel-based T1r maps from the cartilage correlated with standardized uptake value (SUVmax) from lateral tibia (LT) bone. The color
map represents the Pearson correlation R values representing positive and negative correlations. The right side shows the scatterplots of the
average value of the voxels in white dashed boxes from the magnetic resonance (MR) images. The ellipse illustrates the 95% confidence interval.
(Top) The cartilage of the lateral tibia (LT) shows a strong positive correlation with SUVmax from the LT bone (R¼ .74, P¼ .0042). (Middle) The
cartilage in the posterior lateral femur shows a strong positive correlation with SUVmax from the LT bone (R ¼ .71, P ¼ .0062). (Bottom) The
cartilage in the medial femur (MF) shows a strong negative correlation with SUVmax from the LT bone(R ¼ .61, P ¼ .012).
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especially in the P, that was clearly separated into an articular
layer and a bone layer. T1r in the 2 layers was differently
correlated with the slope Ki of the bone. As a result, we rec-
ommend that the cartilage not be treated as a single region,
since several significant clusters were observed locally in the
different cartilage compartments (Figures 3–5). Our method
was more sensitive to local changes in the cartilage and there-
fore early cartilage degeneration together with bone remodel-
ing might provide us with biomarkers for early OA, changes in
which may potentially be reversible.
Although the cartilage and bone has been investigated in
patients with knee OA, it has never been assessed simultane-
ously using the voxel-by-voxel-based concept, relating adjoin-
ing and distance regions, and focusing on cartilage biochemical
degeneration and bone remodeling as early markers of OA.
One of the limitations in this study was the relatively small
sample size and the broad range of disease severity. However,
the results can be used for hypothesis generation for further
elucidating the interaction between bone–cartilage, and clearly
further studies are warranted, for example in patients with
Anterior Cruciate Ligament (ACL) injury who are at risk of
getting OA maybe considered to be a good model for studying
early OA changes.42,43
Not only have we shown that increased uptake of [18F]-NaF
in the knee OA, but we have also shown that quantitative PET
metrics correlate with the semiquantitative (R2 ¼ .7) metrics
consistent with the literature,34 thus supporting the use of both
metrics to characterize bone remodeling. The benefit of the
PET-MR scanner is that it saves time and provides a platform
to study direct correlations between cartilage degeneration and
the dynamic process of bone remodeling providing a better
diagnostic tool for the evaluation of OA. If the kinetic PET
data in patients with OA are replaceable by the static data, one
can save time on the PET imaging and only acquire short
sequences, leaving enough time for example to acquire MR
of both knees instead of one. The PET-MR technology together
with the initial finding of the connection between the bone and
the cartilage can help us understand the disease more thor-
oughly. However, further studies are needed to evaluate these
connections.
The development of effective disease-modifying drugs in
OA is in progress to define the molecular mechanisms involved
in the initiation and progression of OA. The dysregulation in
cartilage breakdown and subchondral bone remodeling may be
improved by selective inhibitors of matrix metalloproteinases
and proteases.44 Irrespective of what the molecular target might
be, if subchondral bone is targeted, or bone–cartilage interac-
tions are to be considered, it will be important to assess these
tissue changes in 3 dimensions across the whole joint.
The interactions between the bone and the cartilage high-
light the role of biomechanical loading and thus demonstrates
linkages between different regions of the entire knee with
regard to the early degenerative changes in cartilage, bone
remodeling, and lesion formation can be used to not just diag-
nose but to also monitor and potentially develop therapeutic
approaches at an early stage in order to prevent severe OA.
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